AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Publishing Language: Chinese | Open Access

Cyclophane cross-links in ribosomally synthesized peptides

School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China
Show Author Information

Abstract

Ribosomally synthesized and post-translationally modified peptides (RiPPs) are an important source of bioactive natural products. The cross-links between aromatic amino acid side chains (cyclophane cross-links) confer structural diversity and complexity. These cross-links are primarily catalyzed by two major types of enzymes: radical S-adenosylmethionine (rSAM) enzymes and cytochrome P450 enzymes. This review focuses on the diverse cyclophane cross-linking patterns introduced by rSAM and P450 enzymes during RiPP biosynthesis, and summarizes the similarities and differences between these enzymatic transformations, aiming to provide some insights for the discovery, engineering, and mechanistic study of this class of natural products.

CLC number: R913;Q67 Document code: A Article ID: 1000-5048(2026)-1-122-11

References

【1】
【1】
 
 
Journal of China Pharmaceutical University
Pages 122-132

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
CHEN Q, CHEN Y. Cyclophane cross-links in ribosomally synthesized peptides. Journal of China Pharmaceutical University, 2026, 57(1): 122-132. https://doi.org/10.11665/j.issn.1000-5048.2025040803

297

Views

7

Downloads

0

Crossref

0

CSCD

Received: 08 April 2025
Published: 25 February 2026
© 2026 The Editorial Office of Journal of China Pharmaceutical University

This is an open access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/).